Veracyte Director Sells $333,216 in Stock (VCYT)
Veracyte (NASDAQ:VCYT) Director Evan/ Fa Jones sold 22,870 shares of Veracyte stock on the open market in a transaction dated Monday, June 9th. The shares were sold at an average price of $14.57, for a total transaction of $333,215.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
A number of analysts have recently weighed in on VCYT shares. Analysts at Cowen and Company raised their price target on shares of Veracyte from $17.00 to $22.00 in a research note on Wednesday, March 19th. They now have an “outperform” rating on the stock. Analysts at Leerink Swann raised their price target on shares of Veracyte from $21.00 to $23.00 in a research note on Wednesday, March 19th.
Veracyte (NASDAQ:VCYT) traded up 0.40% on Monday, hitting $15.00. The stock had a trading volume of 34,726 shares. Veracyte has a 52-week low of $10.88 and a 52-week high of $19.00. The stock has a 50-day moving average of $13.69 and a 200-day moving average of $14.76. The company’s market cap is $317.6 million.
Veracyte (NASDAQ:VCYT) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.32) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.31) by $0.01. The company had revenue of $7.50 million for the quarter, compared to the consensus estimate of $7.19 million. During the same quarter last year, the company posted ($9.04) earnings per share. Veracyte’s revenue was up 70.5% compared to the same quarter last year. Analysts expect that Veracyte will post $-1.32 EPS for the current fiscal year.
Veracyte, Inc is a diagnostics company focused on molecular cytology. The Company focuses on diseases that often require invasive procedures for an accurate diagnosis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.